日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Impact of war on stroke incidence in Ivano-Frankivsk, Ukraine

战争对乌克兰伊万诺-弗兰科夫斯克中风发病率的影响

Shkoruta, Dominika Paula; Senkiv, Vasylyna; Vovchuk, Volodymyr; Popadynets, Oksana; Kotyk, Taras

Development of Novel Pyridine-Thiazole Hybrid Molecules as Potential Anticancer Agents

新型吡啶-噻唑杂化分子作为潜在抗癌剂的开发

Iryna Ivasechko, Ihor Yushyn, Piotr Roszczenko, Julia Senkiv, Nataliya Finiuk, Danylo Lesyk, Serhii Holota, Robert Czarnomysy, Olga Klyuchivska, Dmytro Khyluk, Nataliya Kashchak, Andrzej Gzella, Krzysztof Bielawski, Anna Bielawska, Rostyslav Stoika, Roman Lesyk

Lipid droplet-mediated scavenging as novel intrinsic and adaptive resistance factor against the multikinase inhibitor ponatinib

脂滴介导的清除作用是针对多激酶抑制剂帕纳替尼的新型内在和适应性耐药因素

Englinger, Bernhard; Laemmerer, Anna; Moser, Patrick; Kallus, Sebastian; Röhrl, Clemens; Pirker, Christine; Baier, Dina; Mohr, Thomas; Niederstaetter, Laura; Meier-Menches, Samuel M; Gerner, Christopher; Gabler, Lisa; Gojo, Johannes; Timelthaler, Gerald; Senkiv, Julia; Jäger, Walter; Kowol, Christian R; Heffeter, Petra; Berger, Walter

Nanoformulations of anticancer FGFR inhibitors with improved therapeutic index

具有更高治疗指数的抗癌FGFR抑制剂纳米制剂

Kallus, Sebastian; Englinger, Bernhard; Senkiv, Julia; Laemmerer, Anna; Heffeter, Petra; Berger, Walter; Kowol, Christian R; Keppler, Bernhard K

Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer

临床批准的多激酶抑制剂尼达尼布的内在荧光揭示了溶酶体隔离是 FGFR 驱动的肺癌的耐药机制

Bernhard Englinger, Sebastian Kallus, Julia Senkiv, Daniela Heilos, Lisa Gabler, Sushilla van Schoonhoven, Alessio Terenzi, Patrick Moser, Christine Pirker, Gerald Timelthaler, Walter Jäger, Christian R Kowol, Petra Heffeter, Michael Grusch, Walter Berger